Treatment of Dyslipidemia in HIV

被引：0
|
作者：
Rajagopal V. Sekhar
机构：
[1] Baylor College of Medicine,BCM
来源：
Current Atherosclerosis Reports | 2015年 / 17卷
关键词：
HIV; Dyslipidemia; Therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patients infected with HIV have a high risk of developing dyslipidemia. Effective therapeutic strategies can be challenging due to an increase risk of drug interactions and other comorbidities. Understanding the underlying pathophysiology and the principles of pharmacological and non-pharmacological therapeutic interventions can be of value in the appropriate management of dyslipidemia in the HIV-infected patient.
引用
收藏
相关论文
共 50 条
  • [31] Advances in the treatment of dyslipidemia
    Sabatine, Marc S.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2016, 83 (03) : 181 - 186
  • [32] TREATMENT OF DIABETIC DYSLIPIDEMIA
    DENKE, MA
    GRUNDY, SM
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1989, 17 (01) : 56 - 58
  • [33] Drug treatment of dyslipidemia
    Kim, Sang-Hyun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2016, 59 (05): : 366 - 373
  • [34] Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe
    Zhou, Danai Tavonga
    Kodogo, Vitaris
    Chokuona, Kudzai Fortunate Vongai
    Gomo, Exnevia
    Oektedalen, Olav
    Stray-Pedersen, Babill
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2015, 7 : 145 - 155
  • [35] EFFECT OF SUPPLEMENTATION WITH OMEGA-3 ON DYSLIPIDEMIA IN CHILDREN AND ADOLESCENTS INFECTED WITH HIV ON ANTIRETROVIRAL TREATMENT
    Araujo, M.
    Goehnix, M.
    Escobal, N.
    Agustinho, A.
    Uicich, R.
    ANNALS OF NUTRITION AND METABOLISM, 2013, 63 : 1298 - 1299
  • [36] Prevalence of dyslipidemia in HIV-infected patients on combined antiretroviral treatment in Spain: a qualitative analysis
    Estrada, V
    Masia, M.
    Iribarren, J.
    Lozano, F.
    Miralles, C.
    Olalla, J.
    Santos, J.
    Bernardino, J.
    Dronda, F.
    Domingo, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 126 - 126
  • [37] The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges
    Ahmed, Mohamed H.
    Al-Atta, Ayman
    Hamad, Mahir A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (13) : 1901 - 1909
  • [38] Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics
    Boccara, Franck
    Kumar, Princy
    Caramelli, Bruno
    Calmy, Alexandra
    Lopez, J. Antonio G.
    Bray, Sarah
    Cyrille, Marcoli
    Rosenson, Robert S.
    AMERICAN HEART JOURNAL, 2020, 220 : 203 - 212
  • [39] Evaluation and management of dyslipidemia in patients with HIV infection
    Michael L. Green
    Journal of General Internal Medicine, 2002, 17 : 797 - 810
  • [40] Dyslipidemia among HIV-infected patients
    Wiwanitkit, Somsri
    Wiwanitkit, Viroj
    ANNALS OF AFRICAN MEDICINE, 2014, 13 (03)
12345